Influence of IL15 gene variations on the clinical features, treatment response and risk of developing childhood acute lymphoblastic leukemia in Latvian population

References

• Hunger SP, Mullighan CG. Acute lymphoblastic leukemia in children. N Engl J Med. 2015;373(16):1541–1552. PMID:26465987.
   PubMed Web of Science ®Google Scholar
• Kreile M, Piekuse L, Rots D, et al. Analysis of possible genetic risk factors contributing to development of childhood acute lymphoblastic leukaemia in the Latvian population. Arch Med Sci. 2016;12(3):479–485. PMID:27279837.
   PubMed Web of Science ®Google Scholar
• Gharbi H, Ben Hassine I, Soltani I, et al. Association of genetic variation in IKZF1, ARID5B, CDKN2A, and CEBPE with the risk of acute lymphoblastic leukemia in Tunisian children and their contribution to racial differences in leukemia incidence. Pediatr Hematol Oncol. 2016;33(3):157–167. PMID:27184773.
   PubMed Web of Science ®Google Scholar
• Flohr T, Schrauder A, Cazzaniga G, et al. Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia. Leukemia 2008;22(4):771–782. PMID:18239620.
   PubMed Web of Science ®Google Scholar
• Bader P, Kreyenberg H, Henze GH, et al. Prognostic value of minimal residual disease quantification before allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia: the ALL-REZ BFM Study Group. J Clin Oncol. 2009;27(3):377–384. PMID:19064980.
   PubMed Web of Science ®Google Scholar
• Huynh V, Laetsch TW, Schore RJ, et al. Redefining treatment failure for pediatric acute leukemia in the era of minimal residual disease testing. Pediatr Hematol Oncol. 2017:1–14. PMID:28067581.
   PubMed Web of Science ®Google Scholar
• Hunger SP, Mullighan CG. Redefining ALL classification: toward detecting high-risk ALL and implementing precision medicine. Blood 2015;125(26):3977–3987. PMID:25999453.
   PubMed Web of Science ®Google Scholar
• Moriyama T, Relling MV, Yang JJ. Inherited genetic variation in childhood acute lymphoblastic leukemia. Blood 2015;125(26):3988–3995. PMID:25999454.
   PubMed Web of Science ®Google Scholar
• Yang JJ, Cheng C, Yang W, et al. Genome-wide interrogation of germline genetic variation associated with treatment response in childhood acute lymphoblastic leukemia. Jama 2009;301(4):393–403. PMID:19176441.
   PubMed Web of Science ®Google Scholar
• Dawidowska M, Kosmalska M, Sedek L, et al. Association of germline genetic variants in RFC, IL15 and VDR genes with minimal residual disease in pediatric B-cell precursor ALL. Sci Rep. 2016;6:29427. PMID:27427275.
   PubMed Web of Science ®Google Scholar
• Williams MT, Yousafzai Y, Cox C, et al. Interleukin-15 enhances cellular proliferation and upregulates CNS homing molecules in pre-B acute lymphoblastic leukemia. Blood 2014;123(20):3116–3127. PMID:24700781.
   PubMed Web of Science ®Google Scholar
• Fehniger TA, Suzuki K, Ponnappan A, et al. Fatal leukemia in interleukin 15 transgenic mice follows early expansions in natural killer and memory phenotype CD8+ T cells. J Exp Med. 2001;193(2):219–231. PMID:11208862.
   PubMed Web of Science ®Google Scholar
• Moricke A, Reiter A, Zimmermann M, et al. Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95. Blood 2008;111(9):4477–4489. PMID:18285545.
   PubMed Web of Science ®Google Scholar
• John SW, Weitzner G, Rozen R, et al. A rapid procedure for extracting genomic DNA from leukocytes. Nucleic Acids Res. 1991;19(2):408. PMID:2014181.
   PubMed Web of Science ®Google Scholar
• Lin D, Liu C, Xue M, et al. The Role of Interleukin-15 Polymorphisms in Adult Acute Lymphoblastic Leukemia. PLoS ONE 2010;5(10):e13626. PMID:21049047.
   PubMed Web of Science ®Google Scholar
• Purcell S, Neale B, Todd-Brown K, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81(3):559–575. PMID:17701901.
   PubMed Web of Science ®Google Scholar
• Gjessing HK, Lie RT. Case-parent triads: estimating single- and double-dose effects of fetal and maternal disease gene haplotypes. Ann Hum Genet. 2006;70(Pt 3):382–396. PMID:16674560.
   PubMedGoogle Scholar
• Barrett JC, Fry B, Maller J, et al. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005;21(2):263–265. PMID:15297300.
   PubMed Web of Science ®Google Scholar
• Cario G, Izraeli S, Teichert A, et al. High interleukin-15 expression characterizes childhood acute lymphoblastic leukemia with involvement of the CNS. J Clin Oncol. 2007;25(30):4813–4820. PMID:17947730.
   PubMed Web of Science ®Google Scholar
• Migliorini G, Fiege B, Hosking FJ, et al. Variation at 10p12.2 and 10p14 influences risk of childhood B-cell acute lymphoblastic leukemia and phenotype. Blood 2013;122(19):3298–3307. PMID:23996088.
   PubMed Web of Science ®Google Scholar
• Burmeister T, Bartels G, Groger D, et al. Germline variants in IKZF1, ARID5B, and CEBPE as risk factors for adult-onset acute lymphoblastic leukemia: an analysis from the GMALL study group. Haematologica 2014;99(2):e23–25. PMID:24497567.
   PubMed Web of Science ®Google Scholar
• Aly RM, Taalab MM, Ghazy HF. Influence of interleukin-15 polymorphism on the survival of adult patients with acute lymphoblastic leukemia in Egypt. Leukemia & Lymphoma. 2015;56(1):151–156.
   PubMed Web of Science ®Google Scholar
• Gokkusu C, Aydin M, Ozkok E, et al. Influences of genetic variants in interleukin-15 gene and serum interleukin-15 levels on coronary heart disease. Cytokine 2010;49(1):58–63. PMID:19796965.
   PubMed Web of Science ®Google Scholar